CVE:FLWR - Flowr Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Flowr Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$0.94 -0.03 (-3.09 %) (As of 02/25/2020 03:26 AM ET) Add Compare Today's RangeC$0.90Now: C$0.94▼C$1.0150-Day RangeC$0.94MA: C$1.56▼C$2.0552-Week RangeC$0.90Now: C$0.94▼C$8.42Volume275,681 shsAverage Volume142,753 shsMarket CapitalizationC$100.56 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email The Flowr Corporation cultivates and produces medicinal cannabis in Canada. The company is based in Lake Country, Canada. Industry, Sector and Symbol Stock Exchange CVE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolCVE:FLWR Previous Symbol CUSIPN/A CIKN/A Webhttp://www.flowr.ca/ Phone905-940-3993Debt Debt-to-Equity Ratio15.50 Current Ratio1.85 Quick Ratio1.31Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$7.62 million Price / Sales13.19 Cash FlowC$0.22 per share Price / Cash Flow4.20 Book ValueC$1.40 per share Price / Book0.67Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees78 Outstanding Shares106,979,000Market CapC$100.56 million Next Earnings DateN/A OptionableNot Optionable Receive FLWR News and Ratings via Email Sign-up to receive the latest news and ratings for FLWR and its competitors with MarketBeat's FREE daily newsletter. TSXV:FLWR Rates by TradingView Flowr (CVE:FLWR) Frequently Asked Questions What is Flowr's stock symbol? Flowr trades on the Canadian Venture Exchange (CVE) under the ticker symbol "FLWR." What price target have analysts set for FLWR? 2 Wall Street analysts have issued 1 year price objectives for Flowr's stock. Their forecasts range from C$3.20 to C$4.00. On average, they anticipate Flowr's share price to reach C$3.60 in the next year. This suggests a possible upside of 283.0% from the stock's current price. View Analyst Price Targets for Flowr. What is the consensus analysts' recommendation for Flowr? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Flowr in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Flowr. Has Flowr been receiving favorable news coverage? News articles about FLWR stock have been trending neutral this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Flowr earned a coverage optimism score of 0.4 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 9.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Flowr. Who are some of Flowr's key competitors? Some companies that are related to Flowr include HEXO (HEXO), Next Science (NXS), Benchmark (BMK), ICC Labs (ICC), Amryt Pharma (AMYT), Shield Therapeutics (STX), Green Organic Dutchman (TGOD), Probiotec (PBP), CannTrust (TRST), ESSA Pharma (EPI), WeedMD (WMD), Supreme Cannabis (FIRE), Auscann Group (AC8), Depomed (ASRT) and Delta 9 Cannabis (NINE). What other stocks do shareholders of Flowr own? Based on aggregate information from My MarketBeat watchlists, some companies that other Flowr investors own include Cross Timbers Royalty Trust (CRT), Curaleaf (CURLF), Allena Pharmaceuticals (ALNA), Prospect Capital (PSEC), 1933 Industries (TGIF), AGNC Investment (AGNC), Capitala Finance (CPTA), Corbus Pharmaceuticals (CRBP), Denali Therapeutics (DNLI) and Dova Pharmaceuticals (DOVA). Who are Flowr's key executives? Flowr's management team includes the folowing people: Mr. Vinay Tolia, Co-CEO & Exec. Director (Age 39)Mr. Thomas Flow, Co-Founder, Co-CEO & Exec. Director (Age 41)Mr. Alexander Dann BBA, CPA, CA, Chief Financial Officer (Age 53)Dr. Lyle Oberg, Chief Policy & Medical Officer and Exec. Director (Age 59)Mr. Lance Emanuel, Pres How do I buy shares of Flowr? Shares of FLWR and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is Flowr's stock price today? One share of FLWR stock can currently be purchased for approximately C$0.94. How big of a company is Flowr? Flowr has a market capitalization of C$100.56 million and generates C$7.62 million in revenue each year. Flowr employs 78 workers across the globe.View Additional Information About Flowr. What is Flowr's official website? The official website for Flowr is http://www.flowr.ca/. How can I contact Flowr? The company can be reached via phone at 905-940-3993. MarketBeat Community Rating for Flowr (CVE FLWR)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 32 (Vote Outperform)Underperform Votes: 34 (Vote Underperform)Total Votes: 66MarketBeat's community ratings are surveys of what our community members think about Flowr and other stocks. Vote "Outperform" if you believe FLWR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FLWR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/25/2020 by MarketBeat.com StaffFeatured Article: What are no-load funds?
